OTCMKTS:FCPG First China Pharmaceutical Group (FCPG) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About First China Pharmaceutical Group Stock (OTCMKTS:FCPG) 30 days 90 days 365 days Advanced Chart Get FCPG alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume15,858 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview First China Pharmaceutical Group, Inc. operates through its wholly owned subsidiary Kun Ming Xin Yuan Tang Pharmacies Co. Ltd. (XYT) is engaged in drug logistics and distribution in Yunnan Province, China through drug stores, medical clinics and hospitals. XYT is a provincial pharmaceutical distributor that offers approximately 5,000 drugs, of which approximately 1,000 are over-the-counter drugs, approximately 1,000 are prescription drugs, approximately 2,000 are prepared Chinese medicines and approximately 1,000 are supplements. The Company's short term objective is to broaden its product line from 5,000 products to 30,000 and include significantly more Western medicines as well as traditional Chinese drugs and herbs. By expanding its product line six-fold and offering products at a lower price than major competitors, the Company expects to be able to become its customers' primary distributor, supplying more than 80% of the pharmaceutical products they require. Read More Receive FCPG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First China Pharmaceutical Group and its competitors with MarketBeat's FREE daily newsletter. Email Address FCPG Stock News HeadlinesAstraZeneca Says Current, Former Executives Involved in China ProbeNovember 7, 2024 | msn.comGOP senators eye comprehensive China strategy to curb CCP influenceSeptember 26, 2024 | foxnews.comCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.July 2 at 2:00 AM | Crypto Swap Profits (Ad)Column-China's Failure to Fire Policy Bazooka May Keep Markets in Deep Freeze: McGeeverSeptember 24, 2024 | money.usnews.comChina's failure to fire policy bazooka may keep markets in deep freeze: McGeeverSeptember 24, 2024 | msn.comChina CNPC's global oil, gas investmentAugust 27, 2024 | reuters.comHEADLINES: China protests PCG flagship in PH waters | August 18, 2024August 18, 2024 | msn.comHow FTC's Battle With PBMs Could Reshape The Pharmaceutical IndustryJuly 23, 2024 | forbes.comSee More Headlines FCPG Stock Analysis - Frequently Asked Questions How do I buy shares of First China Pharmaceutical Group? Shares of FCPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of First China Pharmaceutical Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that First China Pharmaceutical Group investors own include SES AI (SES), American Heritage International (AHII), Affinity Networks (AFFN), Astera Labs (ALAB), Akoustis Technologies (AKTS) and American Battery Technology (ABAT). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:FCPG CIK1432254 Webwww.firstchinapharma.com Phone+86-852-21381668FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free Report This page (OTCMKTS:FCPG) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Pentagon just made a National Security move...This "awesome resource" could power America for 30,000 years... We sent one of our smartest researchers.......Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First China Pharmaceutical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share First China Pharmaceutical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.